CBIO is Crescent Biopharma, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $20.40. Market cap: $689M. Capital Quality Rank: 37/100 — Stagnant mediocrity.
Stock snapshot
| Price | $20.40 |
| Market cap | $689M |
| Sector | Healthcare |
| Exchange | NCM |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 37 / 100 · Stagnant mediocrity |
| Revenue CAGR (3y) | -19.7% |
| Shareholder buyback yield | 15.00% |
| Altman Z-score zone | Distress |
About CBIO
Crescent Biopharma Inc is a biopharmaceutical company developing novel therapeutics to treat solid tumors, led by CR-001, a proprietary anti-PD-1/anti-VEGF bispecific antibody. Crescent's pipeline product CR-001 has the potential to deliver improved clinical efficacy and safety over pembrolizumab. CR-001 is a new molecular entity designed to replicate the functional properties of ivonescimab, a cooperative bispecific anti-PD-1/anti-VEGF antibody in development by Akeso Biopharma and Summit Therapeutics that delivered improved efficacy in a head-to-head Phase 3 clinical trial versus Keytruda in non-small cell lung cancer. The company focuses on advancing its second and third programs, CR-002 and CR-003, which are antibody drug conjugates (ADCs) against validated oncology targets.
Related non-dividend companies
Other non-dividend stocks investors research alongside CBIO. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is CBIO's current stock price?
CBIO (Crescent Biopharma, Inc.) is currently trading at $20.40.
Does CBIO pay a dividend?
CBIO (Crescent Biopharma, Inc.) does not currently pay a regular dividend.
What is CBIO's Capital Quality Rank?
CBIO has a Capital Quality Rank of 37/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track CBIO in DiviDrip
Add CBIO to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search CBIO and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.